Immunization against poly-N-acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity

Microbial invasion into the intestinal mucosa after allogeneic hematopoietic cell transplantation (allo-HCT) triggers neutrophil activation and requires antibiotic interventions to prevent sepsis. However, antibiotics lead to a loss of microbiota diversity, which is connected to a higher incidence o...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 116; no. 41; pp. 20700 - 20706
Main Authors Hülsdünker, Jan, Thomas, Oliver S., Haring, Eileen, Unger, Susanne, Núñez, Nicolás Gonzalo, Tugues, Sonia, Gao, Zhan, Duquesne, Sandra, Cywes-Bentley, Colette, Oyardi, Ozlem, Kirschnek, Susanne, Schmitt-Graeff, Annette, Pabst, Oliver, Koenecke, Christian, Duyster, Justus, Apostolova, Petya, Blaser, Martin J., Becher, Burkhard, Pier, Gerald B., Häcker, Georg, Zeiser, Robert
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 08.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Microbial invasion into the intestinal mucosa after allogeneic hematopoietic cell transplantation (allo-HCT) triggers neutrophil activation and requires antibiotic interventions to prevent sepsis. However, antibiotics lead to a loss of microbiota diversity, which is connected to a higher incidence of acute graft-versus-host disease (aGVHD). Antimicrobial therapies that eliminate invading bacteria and reduce neutrophil-mediated damage without reducing the diversity of the microbiota are therefore highly desirable. A potential solution would be the use of antimicrobial antibodies that target invading pathogens, ultimately leading to their elimination by innate immune cells. In a mouse model of aGVHD, we investigated the potency of active and passive immunization against the conserved microbial surface polysaccharide poly-N-acetylglucosamine (PNAG) that is expressed on numerous pathogens. Treatment with monoclonal or polyclonal antibodies to PNAG (anti-PNAG) or vaccination against PNAG reduced aGVHD-related mortality. Anti-PNAG treatment did not change the intestinal microbial diversity as determined by 16S ribosomal DNA sequencing. Anti-PNAG treatment reduced myeloperoxidase activation and proliferation of neutrophil granulocytes (neutrophils) in the ileum of mice developing GVHD. In vitro, anti-PNAG treatment showed high antimicrobial activity. The functional role of neutrophils was confirmed by using neutrophil-deficient LysMcre Mcl1fl/fl mice that had no survival advantage under anti-PNAG treatment. In summary, the control of invading bacteria by anti-PNAG treatment could be a novel approach to reduce the uncontrolled neutrophil activation that promotes early GVHD and opens a new avenue to interfere with aGVHD without affecting commensal intestinal microbial diversity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: J.H., C.K., B.B., G.B.P., G.H., and R.Z. designed research; J.H., O.S.T., E.H., S.U., N.G.N., S.T., Z.G., S.D., C.C.-B., O.O., S.K., A.S.-G., O.P., C.K., P.A., and M.J.B. performed research; B.B. and G.B.P. contributed new reagents/analytic tools; J.H., O.S.T., E.H., S.U., N.G.N., S.T., Z.G., S.D., C.C.-B., O.O., S.K., A.S.-G., O.P., C.K., J.D., P.A., M.J.B., B.B., G.B.P., G.H., and R.Z. analyzed data; and J.H., J.D., G.B.P., G.H., and R.Z. wrote the paper.
1B.B., G.B.P., G.H., and R.Z. contributed equally to this work.
Edited by John J. Mekalanos, Harvard University, Boston, MA, and approved August 27, 2019 (received for review May 17, 2019)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1908549116